The aim of the study was to evaluate the distribution and number of mast cells and eosinophils in rat mammary gland tumours induced by N-Nitroso-N-methylurea. The highest density of mast cells was found in cystic papillary adenocarcinomas of grade II. Eosinophils were detected only in the cystic papillary adenocarcinoma of grades I and II, in non-invasive cribriform adenocarcinoma and comedo-type carcinoma. Mast cell populations were observed perivascularly in the tumour stroma, in the host tumour interface, as well as in necrotic areas of neoplasms. Mast cells were observed to be intact according to their morphological changes, collectively referred to as degranulation. The obtained results indicate that mast cells and eosinophils play an important role in tumour micro-environment formation. The increased density of these cells in experimentally-induced rat mammary gland tumours suggests a poor prognosis in these cancers. Our results also confirmed that rat mammary gland tumours are good models for the study of breast cancers.
Introduction
The occurrence of tumorous diseases presents a substantial social and medical problem all over the world. The mammary gland, the additional skin gland in mammals, is a frequent source of tumours (10) .
The best model for the study of premalignant and malignant phases of breast tumours is experimental mammary carcinogenesis in female rats induced by various chemical carcinogens. N-Nitroso-N-methylurea (NMU) and 7, 12-dimetylbenz(a) antracen (DMBA) are most commonly used (10, 30) . This is mainly due to the speed at which lesions arise within almost all experimental animals as well as the possibility of detecting a large number of premalignant and malignant lesions (30) .
Since Erlich's (1879) first description of mast cells and their association with some neoplasms, numerous reports have appeared confirming their peripheral distribution around a variety of human and experimentally-induced animal tumours (5) . Today they are considered as flexible, versatile tissue elements, which have an important function in a wide variety of biological processes starting from inflammation and continuing up to the immune reactions through angiogenesis, tissue remodelling, and tumour reparation (2) .
Eosinophils were recognised in cellular infiltrates of tumours even in early histological studies of human cancers (18) and in several animal tumour models (6) . Clinical observations confirmed the appearance of eosinophils particularly those of epithelial origin (e.g. colon and breast tumours) (20) . However, there are discrepancies in reports of tumour-associated tissue eosinophilia (TATE) or evidence of eosinophil degranulation in various types of cancers (6) . On the other hand, there are no reports on whether tissue eosinophilia and mast cell infiltration can participate in tumour progression/regression.
Eosinophils interact with various innate immune cells (the most prominent of which are mast cells and myeloid-derived dendritic cells) and adaptive immune cells (primarily T-cells). They regulate mast cell functions through the release of granule proteins and cytokines: major basic protein (MBP), eosinophil peroxidase (EPO), and eosinophilic cation protein (ECP) trigger mast cells to release histamine TNF-α, IL-8, granulocyte macrophage colony-stimulating factor (GM CSF), and prostaglandine-2 (6) .
The goal of the paper was to evaluate the density of eosinophils and mast cells in relation to the morphological type of mammary gland carcinoma induced by NMU in rats.
Material and Methods
Animals. Thirty virgin female Sprague Dawley (SD) rats were obtained at 35 d of age from ANLAB s.r.o. (Czech Republic). After one week's quarantine, the animals were kept in a vivarium under standard housing conditions (21-23ºC air temperature, 50 ± 10% humidity, and 12 h light-dark daily regimen cycle). The animals were housed in solid plastic cages (with shavings bedding), two rats per cage, one of them marked with water resistant pen on the tail. The rats were fed a commercial pellet diet (MP-OŠ-06, Miško P., Serbia) and tap water ad libitum throughout the study (18 weeks).
Experiment. Crystalline NMU (Sigma-Aldrich Chemical Company, USA) was dissolved in warm 0.9% NaCl acidified to pH 5.0 with acetic acid. The compound was administered intraperitoneally (0.5 mL per animal) in two doses (50 mg/kg b.w.) on days 42 and 49. Solutions were used within 15 min after preparation (9) . Palpations of cervical, thoracic, and abdominal-inguinal mammary glands were performed weekly starting at week four post NMUinjection (p.i.).
Animals were sacrificed 16 and 18 weeks p.i. The mammary glands of ten control rats (without the application of NMU) as well as induced tumours were removed and coded according to the location. For histological examination samples of 0.5 cm 3 were immediately fixed in 10% formalin for 48 h. Subsequently, the samples were processed by standard histological techniques. The sections were stained with haematoxylin and eosin. Evaluation of tumour differentiation was done according to Russo and Russo (17) . For mast cell counting, the sections were stained with Giemsa-Romanowsky (G-R) solution (PENTA s.r.o., Czech Republic). The staining allows the detection of mast cells containing metachromatic (purple) cytoplasmic granules (25) .
Quantification of mast cells and eosinophils was performed on two or three slides with each type of induced tumour. The measurement was performed with a Nikon Labophot 2 light microscope (Nikon, Japan), at 200 × magnification where 16 fields (two by eight) of 1280 × 960 pixels (created by used software) were analysed in concordance with mast cell and eosinophil occurrence. The scoring was performed with NIS-Elements Advanced Research 3.0 Programme (Nikon, Japan) using the functions Annotations and Measurements, Object count. Each slide was evaluated in duplicate.
Statistical analysis. Mast cells and eosinophils were statistically analysed by ANOVA with post-hoc Tukey's multiple comparison test.
Results
The administration of NMU in doses of 50 mg/kg b.w. on postnatal days 42 and 49 did not induce acute toxicity in treated animals. The first palpable tumours were evident in weeks 8 and 12 p.i. as solitary, and later (13-18 weeks) as multiple lesions, particularly in the abdomino-inguinal and cervical mammary glands. Tumours were ovalshaped and solid or of rigidly elastic consistency. Some of them were necrotic, with diameter from 0.5 to 2.5 cm.
Histological examination revealed different types of adenocarcinomas: cystic papillary and noninvasive cribriform tumours. Carcinomas were also revealed: the ductal solid and comedo types.
In control animals, mast cells were found to be randomly dispersed in the connective tissue, between fat deposits and around small blood vessels in mammary gland tissue. In contrast, the tumour specimens showed an apparent increase in the numbers of the cells. They were predominantly located perivascularly (Fig. 1) , in the tumour stroma (Fig. 2) as well as at the tumour-host interface. In some tumours (cystic papillary adenocarcinomas of grades I and II and comedo-type carcinomas) the proliferation of interstitial tissue was observed. Intact mast cells were frequently observed alongside fibroblasts in the stroma close to the tumour cells. Morphological changes in mast cells with depletion of the surrounding matrix (Fig. 3) were observed mainly in the fibrous connective tissue at the hosttumour interface. The nuclei and cell shapes were changed and their outlines were not sharp. The integrity of the cytoplasmic membrane was lost by the "escape" of cytoplasmic granules into extracellular space (Fig. 4) . The highest numbers of mast cells were observed in grade II papillary (cystic) adenocarcinomas and the lowest in comedo-type carcinomas. Mast cell data are summarised in Table 1 .
Eosinophils were present in cystic papillary adenocarcinomas of grade I and grade II, noninvasive cribriform adenocarcinomas, and comedotype carcinomas, but not in ductal solid carcinomas. As shown in Table 1 , differences were not significant. 
Discussion
The current study demonstrated the highest density of mast cells in NMU-induced rat cystic papillary mammary gland adenocarcinomas of grade II. Mast cells were found predominantly perivascularly and in the tumour stroma. The presence of mast cells in the stroma with infiltration of inflammatory cells is an early effect of carcinogen administration in mammary gland carcinogenesis (13) . Correspondingly, in human breast biopsies the number of mast cells is significantly increased in malignant tumours as compared to benign lesions (8) . Mastocytes accumulate in response to the numerous chemoattractants (27) such as regulated on activation, normal T-cell expressed and secreted (RANTES) or monocyte chemotactic protein-1 (MCP-1), and are associated with poor prognosis (14) . It is also known that mast cells release soluble factors (11) , which contribute to tumour angiogenesis (heparin, vascular endothelial growth factor (VEGF), and vascular permeability factor (VPF)), growth (plateletderived growth factor (PDGF), stem cell factor (SCF), and nerve growth factor (NGF)), and neoplastic cell proliferation (histamine through H1 receptors), one of which also serves as a tumour mitogen and chemotactic factor for tumour cells (interleukin-8 (IL-8)) (29) . We can consequently hypothesise that the highest density of mast cells detected in low differentiated tumours represents one of the measures confirming their biological behaviour.
Tumour cells and their stroma co-evolve. The stroma consists of a compilation of cells which includes fibroblasts, adipocytes, endothelial cells, and innate immune cells (macrophages, neutrophils, and lymphocytes). Additional immune cell populations (mast cells and eosinophils) have a less-welldocumented role in carcinogenesis, and are not consistent with tumour stroma-residing cell types (12) . While none of these cells are malignant due to the surrounding microenvironment, their interactions with each other, and directly or indirectly with the cancer cells, allow them to acquire an abnormal phenotype and altered function (12) . In our work, the morphological changes in some mast cells, collectively referred to as mast cell degranulation (19) , were associated with localised stroma depletion and degradation. The degree of degranulation was different not only between individual samples but even between different places within the same tumour. This was not seen in unaltered interstitial tissue. Similar findings were obtained from human mammary adenocarcinoma biopsies, in which accumulated mast cells in an area of intense tumour infiltration appeared to be intact. However, mast cells in an area of marginal tumour growth appeared to be degranulated (19) .
The enhancement of mast cells and their degranulation with stromal lysis have several explanations. It is known that mast cells produce a variety of proteolytic enzymes (24) , particularly metalloproteinase, representing the majority of proteolytic components (1). Together with tryptase, which is the most significant mast cell protease and probably resistant to the plasma antiproteinase (23), these enzymes may contribute to fibrinolysis (22) and activation of a cascade mechanism. The consequent depletion and destruction of the tumour stroma (3, 16) is one of the key points necessary for tumour invasiveness and metastatic spread (5, 29) .
The accumulation of eosinophils in the tumour stroma has been documented in various tumour types. Recruitment of eosinophils to the tumour depends on C-C motif chemokine 11 (chemokine CCL11) also known as eosinophil chemotactic protein and eotaxin-1, which is highly selective for this cell type. It has been suggested that eosinophil-stimulated proliferation is at least partially mediated by VEGF. However, whether the presence of eosinophils represents a positive or negative prognostic factor is tumour-entity dependent (12, 26) . In this work, eosinophil occurrence was associated with malignant low-differentiated tumours (cystic papillary adenocarcinoma of grade I and grade II, and non-invasive cribriform adenocarcinoma) with only minimum frequency. Eosinophils were not found in ductal solid carcinomas, which are characterised as well-defined nodules composed of well differentiated tubules separated by fibrovascular cores, and have an excellent prognosis (21) . This is in accordance with the fact that eosinophils associated with different types of malignant tumours (colon, breast, lung etc.) contribute to tumour invasion via VEGF production, VEGF being an angiogenesis promoter.
The presence of tumour necrosis in the pathological specimen may reflect tumour biology and provide additional prognostic information. It is believed that tumour necrosis occurs when tumours outgrow their blood supply and, therefore, histologic tumour necrosis has been proposed as an indicator of tumour aggressiveness (7, 15) . The comedo-type carcinomas observed in this study are more frequently found in animals that have been treated with chemical carcinogens at a young age. These lesions appear as distended ductal structures lined by a multilayered epithelium and have centrally located necrotic debris (17) .
The density of eosinophils and mast cells were contradictory in comedo-type carcinomas, where the lowest density and perivascular localisation for mast cells was observed. It is well-known that mast cells are located mainly perivascularly in tissues, including tumorous tissue (28) . That is why it is supposed that their very low incidence in this type of induced rat mammary gland tumour coincides with the presence of avascular necrotic tissue. It correlates with increased tumour size and high-grade disease found also in breast cancers (7) .
Conversely, the tendency for the density of eosinophils to increase was found in comedo-types carcinomas. Presumably, eosinophil recruitment occurs by migration from outside of the tumour through the capsule and viable regions, as tumours display little evidence of vascularisation movement of eosinophils directly to the necrotic regions. Eosinophils accumulate in the necrotic regions first and foremost because this is the destination of the cells' vectorial movement. Although the mechanism of this accumulation remains unelucidated, the ability of eosinophils to release copious amounts of vasoactive leukotrienes potentially promotes localised angiogenesis, which suggests that this eosinophilia may represent a physiological response to localised hypoxia. This relationship between eosinophils and necrotic regions would also create a positive feedback loop that may explain the increased eosinophil accumulation occurring as tumours enlarge. Eosinophils recruited to the necrotic regions of tumours may expand these areas of necrosis through their destructive effector functions (e.g., release of toxic cationic proteins such as MBP) and increase the release of one or more chemotactic factors, which, in turn, leads to the recruitment of yet more eosinophils (4).
In conclusion, the highest density of mast cells was found in cystic papillary adenocarcinomas of grade II. Eosinophils were detected only in some lowdifferentiated malignant tumours. Mast cell populations were observed perivascularly in the tumour stroma, in the host tumour interface, and in necrotic areas of neoplasms. They were observed in intact form, and morphological changes, collectively referred to as degranulation, were also seen. The obtained results indicate that mast cells and eosinophils play an important role in tumour micro-environment formation, and further suggest a poor prognosis for these cancers because of the increased density of these cells. Our results also confirmed that rat mammary gland tumours are good models for the study of breast cancers.
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